Table 1.
Clinical characteristics of the study patients
| Characteristic | EG (n = 49) | LG (n = 27) | P-value |
|---|---|---|---|
| Sex | 0.577 | ||
| Female | 12 (24.5) | 9 (33.3) | |
| Male | 37 (75.5) | 18 (66.7) | |
| Age (yr) | 22.9 ± 5.9 | 26.6 ± 10.5 | 0.103 |
| CD distribution | 0.326 | ||
| Colon | 5 (10.2) | 2 (7.4) | |
| Ileocecal | 38 (77.6) | 18 (66.7) | |
| Rectum | 1 (2.0) | 3 (11.1) | |
| SB | 5 (10.2) | 4 (14.8) | |
| Fistula type | 0.224 | ||
| Intersphincteric | 19 (38.8) | 6 (22.2) | |
| Transsphincteric | 30 (61.2) | 21 (77.8) | |
| Mean duration of CD | 13.3 ± 25.1 | 12.4 ± 25.1 | 0.886 |
| Previous CD medication | 0.802 | ||
| No | 28 (57.1) | 17 (63.0) | |
| Yes | 21 (42.9) | 10 (37.0) | |
| Follow-up period (mo) | 21.0 ± 11.6 | 34.5 ± 18.4 | 0.001 |
Values are presented as number (%) or mean ± standard deviation.
EG, early group; LG, late group; CD, Crohn disease.